Akebia Therapeutics Inc logo

Akebia Therapeutics Inc

NEW
STU:AX9 (USA)  
€ 0.82 -0.31 (-27.44%) Aug 6
At Loss
P/B:
9.14
Market Cap:
€ 228.85M ($ 263.66M)
Enterprise V:
€ 141.81M ($ 163.39M)
Volume:
0
Avg Vol (2M):
9.23K
Trade In:

Akebia Therapeutics Inc (STU:AX9) Dividend

Akebia Therapeutics Inc (STU:AX9) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -13%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: STU:AX9 Dividend

Does Akebia Therapeutics Inc (STU:AX9) pay a dividend?

Akebia Therapeutics Inc (STU:AX9) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Akebia Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Akebia Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -13% over the past 3 years.

What are dividend-paying alternatives to Akebia Therapeutics Inc?

For dividend-paying alternatives in Akebia Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.